Selective antimetastatic effect of heparins in preclinical human melanoma models is based on inhibition of migration and microvascular arrest

Clinical and Experimental Metastasis

Volumn 22, Issue 1, 2005, Pages 69-76

  Bereczky, Bíborka ^a   Gilly, Réka ^a   Rásó, Erzsébet ^a   Vágó, Ágnes ^a   Tímár, József ^a   Tóvári, József ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

Cell migration; Human melanoma xenograft; Low molecular weight heparin (LMWH); Metastasis; Unfractionated heparin (UFH)

Indexed keywords

DALTEPARIN; HEPARIN; HEPARIN DERIVATIVE; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; RECOMBINANT HIRUDIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; HUMAN; HUMAN CELL; IN VIVO CULTURE; LIVER METASTASIS; MELANOMA CELL; METASTASIS INHIBITION; MITOSIS INHIBITION; MOLECULAR WEIGHT;

ANIMALS; ANTICOAGULANTS; CAPILLARIES; CELL PROLIFERATION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HEMOSTASIS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MELANOMA; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

EID: 23944442968     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-005-3859-6     Document Type: Article

References (39)

1. GYH Lip BSP Chin AD. Blann 2002 Cancer and the prothrombotic state Lancet Oncol 3 27 34
2. A Letai DJ. Kuter 1999 Cancer. Coagulation and anticoagulation Oncologist 4 443 9
3. D Green RD Hull R Brant 1992 Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin Lancet 339(8807) 1476
4. AYY Lee MN Levine RI Baker 2003 Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer N Engl J Med 349 146 53
5. LR Zacharski WG Henderson FR Rickles 1981 Effect of warfarin on survival in small cell carcinoma of the lung JAMA 145 831 5
6. LP Zacharski WG Henderson FR Rickles 1984 Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate Cancer 53 2046 52
7. AP Chahinian KJ Propert JH Ware 1989 A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the cancer and leukemia group B J Clin Oncol 7 993 1002
8. B Lebeau C Chastang J-M Brechot 1994 Subcutanous heparin treatment increases survival in small cell lung cancer Cancer 74 38 45
9. GF von Tempelhoff J Harenberg F Niemann 2000 Effect of low molecular weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: A prospective randomized double-blind trial Int J Oncol 16 815 24
10. S Constantini A Kanner A Friedmann 2001 Safety of perioperative minidose heparin in patients undergoing brain tumor surgery: a prospective, randomized double-blind study J Neurosurg 94 918 21
11. F Robert E Busby MB Marques 2003 Phase II study of docetaxel plus enoxaparin in chemotherapy naïve patients with metastatic non-small cell lung cancer: Preliminary results Lung Cancer 42 237 45
12. SS Smorenburg CJF. van Noorden 2001 The complex effects of heparins on cancer progression and metastasis in experimental studies Pharmacol Rev 59 93 105
13. L Borsig R Wong J Feramisco 2001 Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis Proc Natl Acad Sci USA 98 3352 7
14. L Borsig R Wong RO Hynes 2002 Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis Proc Natl Acad Sci USA 99 2193 8
15. RJ Ludwing B Bochme M Podda 2004 Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis Cancer Res 64 2743 50
16. M Martin M. Clynes 1993 Comparison of 5 microplate colorimetric assays for in vitrocytotoxicity testing and cell proliferation assays Cytotechnology 11 49 58
17. E Rásó L Mészáros A Albini 2004 A WT1 expressing metastatic human Kaposi sarcoma xenograft model Pathol Oncol Res 10 22 5
18. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR). Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition). Br J Cancer 1998; 77: 1-10.
19. A Amirkoshravi SA Mousa M Amaya 2003 Antimetastatic effect of tinzaparin, a low-molecular-weight heparin J Thromb Haemost 1 1972 6
20. ML Nierodzik A Plotkin F Kajumo S. Karpatkin 1991 Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo J Clin Invest 87 229 36
21. N Esumi D Fan IJ. Fidler 1991 Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor Cancer Res 51 4549 56
22. MA Booden LB Eckert CJ Der J. Trejo 2004 Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion Mol Cell Biol 24 1990 9
23. D Darmoul V Gratiuo H Devaud 2003 Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells Am J Pathol 162 1503 13
24. C Tellez M McCarty M Ruiz H. Bar-Eli 2003 Loss activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma J Biol Chem 178 46632 42
25. M Hejna M Radere CC. Zielinski 1999 Inhibition of metastases by anticoagulants J Natl Cancer Inst 91 22 36
26. A Koenig K Norgard-Sumnicht R Linhardt 1998 Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins J Clin Invest 101 877 89
27. L Wang JR Brown A Varki 2002 Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins J Clin Invest 110 127 36
28. R Sasisekharan Z Shriver G Venkataraman 2002 Roles of heparan-sulphate glycosaminoglycans in cancer Nat Rev Cancer 2 521 8
29. A-Q Ma J-G. Geng 2000 Heparan sulfate-like proteoglycans mediate adhesion of human malignant melanoma A375 cells to P-selectin under flow J Immunol 165 558 65
30. B Döme B Somlai A Ladányi 2001 Expression of CD44v3 splice variant is associated with the visceral metastatic phenotype of human melanoma Virchows Arch 439 628 35
31. J Tímár K Lapis J Dudás 2002 Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer Sem Cancer Biol 12 173 86
32. J Tímár CS Diczházi I Bartha 1995 Modulation of heparan-sulphate/chondroitin-sulphate ratio by glycosaminoglycan biosynthesis inhibitors affects liver metastatic potential of tumor cells Int J Cancer 62 755 61
33. K Fazekas E Rásó M Zarándi 2002 Basic HGF-like peptides inhibit generation of liver metastases in murine and human tumor models Anticancer Res 22 2575 80
34. MS Da Silva JA Horton JM Wijelath 2003 Heparin modulates integrin-mediated cellular adhesion: Specificity of interactions with alpha and beta integrin subunits Cell Commun Adhes 10 59 67
35. M Trikha J Tímár A Zacharek 2002 Role for β3 integrins in human melanoma growth and survival Int J Cancer 101 156 67
36. M Trikha Z Zhou J Tímár 2002 Multiple roles for platelet gpIIb/IIIa and αvβ3 integrins in tumor growth, angiogenesis and metastasis Cancer Res 62 2824 833
37. P Friedl K. Wolf 2003 Cell-cell invasion and migration: Diversity and escape mechanisms Nat Rev Cancer 3 362 74
38. K Wolf R Müller S Borgmann 2003 Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases Blood 102 3262 9
39. P Thodiyil AK. Kakkar 2002 Can low-molecular-weight heparins improve outcome in patients with cancer? Cancer Treat Rev 28 151 5